GLP1R and type 2 diabetes mellitus: Although it was thought to have no potential as a glucose-lowering therapy because of observations showing no insulinotropic effect from supraphysiological infusion in people with T2DM, recent evidence showed that there is a synergistic effect of GLP-1 and GIP, resulting in significantly increased insulin response and glucagonostatic response [10].